MIBG Therapy for Pheochromocytomas and Paragangliomas
2 Visningar
• 07/02/23
0
0
Bädda in
administrator
Prenumeranter
Dr. David Mankoff discusses meta-Iodobenzylguanidine (MIBG) therapy, which is a highly targeted therapy for treatment of pheochromocytomas and paragangliomas, at the 2012 Focus on Neuroendocrine Tumors Conference.
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna